We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of EPZM yet.

EPZM Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2022, worth a combined $4K — down 100% from $187M a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of EPZM and 0 opened new positions — a net loss of 93 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RP Management, exiting entirely with an estimated $46.8M sold.

  • 0 institutional investors held Epizyme, Inc (EPZM) as of Q3 2022, down from 93 in Q2 2022.
  • Funds reported $4K of Epizyme, Inc stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Epizyme, Inc positions in Q3 2022 and 93 closed out, a net change of -93 holders.
  • The largest Epizyme, Inc seller in Q3 2022 was RP Management, an estimated $46.8M sold.

Based on aggregated 13F filings for Q3 2022.